MedAdvisor Limited (AU:MDR) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedAdvisor Limited is on track to achieve record financial results for FY24 with strong growth momentum in the U.S. and Australia, leading to its first full-year EBITDA and NPAT profit, with revenues expected to increase by $22-25 million. The company’s success is driven by its THRiV programs in the U.S. and new transaction fees in Australia, with a positive outlook for continued growth into FY25.
For further insights into AU:MDR stock, check out TipRanks’ Stock Analysis page.